Between the 2017-2018 and 2023-2024 influenza seasons, the use of antiviral therapy in pediatric patients with influenza declined in both inpatient and outpatient settings.

A systematic review and meta-analysis led by Shandong University in China has evaluated the comparative efficacy and safety ...

More Americans are getting infected with seasonal influenza and seeking care, a regular occurrence this time of year.

A single 40-mg dose of the antiviral drug suraxavir marboxil significantly shortened flu symptom resolution time in male ...